Complete our short survey on ligand binding assays and be the first to receive our informative infographic collated from the survey results.
As part of our Spotlight on flow cytometry, we carried out a survey to gain an insight into the trends, challenges and developments associated with this technique – find out the results in this informative infographic.
In this interview, Wenying Jian (Janssen Research & Development, Johnson & Johnson; NY, USA) describes the basic principles of hybrid LBA/LC–MS and how this technique can be used to quantify proteins.
Hear more about the recent mass spectrometry product launches from SCIEX announced at ASMS 2019, including the new Acoustic Ejection Mass Spectrometry technology, in this interview with Neil Walsh (SCIEX; MA, USA).
In this interview, Zamas Lam (QPS; DE, USA) discusses various methods that can be used to quantify oligonucleotide drugs and the progress that has been made to regulate and standardize oligonucleotide analysis in recent years.
Product: Gyrolab® xPand – the automated, high- throughput immunoassay system that maximizes productivity in biotherapeutic discovery, development and production
Gyros Protein Technologies AB, a pioneer in automated nanoliter-scale immunoassay platforms and leading provider of peptide synthesizers and reagents has developed Gyrolab® xPand to provide high-throughput, flexibility and rapid analysis of large sample numbers for a range of biotherapeutic applications. The proprietary Gyrolab CD technology, with highly reproducible nanoliter microfluidics, is integrated with Gyrolab platforms to automate nanoliter-scale immunoassays with parallel processing, using laser-induced fluorescence detection.
In this installment of Robert MacNeill’s (Covance) column, Robert discusses where to best place specific QC samples within a calibration range for a methodology, and the challenges associated with establishing suitable nominal levels for the internal standard concentration.
In this interview, Annick De Vries (Sanquin; Amsterdam, Netherlands) discusses how personalized sampling can be utilised to achieve optimal PK/PD data, and how PK measurements translate into real life.
In this editorial Sally Fischer (Genentech; CA, USA) explores ligand binding assay technologies: how to match the right tool to the bioanalytical challenge.
In this methodology video, Derek Davies (Francis Crick Institute; London, UK) and Rachael Walker (Babraham Institute; Cambridge, UK) give an overview of how flow cytometry works, why it is important and where the technique is heading in the future.